| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-06 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.22 | 3e-05 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-05 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |